Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Jin Chui Youn
Introduction
Jin Chui Youn is a prominent inventor based in Daejeon, South Korea. He has made significant strides in the field of immunotherapy, particularly through his work on antibodies that target programmed cell death 1 (PD-1). His innovative approach has the potential to revolutionize cancer treatment.
Latest Patents
Jin Chui Youn holds a patent for an "Antibody to programmed cell death 1 (PD-1) and use thereof." This patent discloses an antibody to human PD-1 or an antigen-binding fragment thereof. It includes a nucleic acid encoding the antibody, a vector containing the nucleic acid, and an isolated cell transformed with the vector. The patent also outlines a method for producing the antibody and a composition for preventing or treating cancer. The novel antibody can bind to PD-1 and inhibit its activity, making it useful for developing immunotherapeutic agents for various diseases associated with PD-1.
Career Highlights
Jin Chui Youn is currently associated with Y-Biologics Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in treating cancer and other diseases.
Collaborations
Some of his notable coworkers include Jae Eun Park and Soo Young Kim, who contribute to the innovative environment at Y-Biologics Inc.
Conclusion
Jin Chui Youn's contributions to the field of immunotherapy through his patent on PD-1 antibodies highlight his role as a leading inventor in cancer treatment. His work exemplifies the impact of innovative research on healthcare advancements.